"The development of products to identify morning hypertension underscores Omron Healthcare's dedication to empowering people to detect and prevent illnesses and conditions before it's too late to notify a physician," said Isao Ogino, Chief Executive Officer, Omron Healthcare. "Our aim is to help both doctors and patients by providing an at-home solution to help detect not only hypertension, but now morning hypertension as well."
The HEM-780, HEM-790IT and HEM-670IT blood pressure monitors are available at pharmacies nationwide. For more information on morning hypertension, please visit http://www.bpnumbers.com.
About Omron Healthcare, Inc.
Omron Healthcare, Inc., located in Bannockburn, IL, a northern suburb
of Chicago, is the North and South American subsidiary of Omron Healthcare
group. A leading manufacturer and distributor of blood pressure monitors
for home use, Omron Healthcare group is a market leader in blood pressure
monitoring with over 70 million of its monitors sold worldwide to date.
Omron Healthcare is committed to offering clinically proven, innovative
weight management and thermometry products and devices for use in treatment
of respiratory conditions, all with the aim of helping people achieve
greater compliance and quality of life. With the April 2006 acquisition of
the Colin(R) brand of blood pressure monitoring products for hospitals,
clinics, and physician offices, Omron Healthcare has a unique position as a
company offering a wide array of medical devices for use in sites ranging
from hospitals to the home. For more information, visit
http://www.omronhealthcare.com and for Colin products, visit
* The American Heart Association identifies an upper limit of normal
|SOURCE Omron Healthcare, Inc.|
Copyright©2008 PR Newswire.
All rights reserved